Parental response to health risk information: Experimental results on willingness-to-pay for safer infant milk formula

Isabell Goldberg, Jutta Roosen, Rodolfo M. Nayga, Jr

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Enterobacter sakazakii, a pathogen that can be found in powdered infant milk formula, can cause adverse health effects on infants. Using Vickrey auction, this study examines parents' willingness to pay (WTP) for a quality assurance label on powdered infant milk formula. The influence of ambiguity with the incidence rate information and provision of safe-handling information on WTP are also evaluated using three experimental treatments. Our findings generally imply that parents significantly value a quality assurance label. The mean price premium parents are willing to pay for the safer and quality assurance labelled powdered infant milk formula ranges from 61 to 133 Eurocents per 100 grams (53-116% of the base price per 100 grams) depending on the treatment. While no ambiguity effects are generally found, provision of safe-handling information significantly reduced WTP to 39-69 Eurocents per 100 grams depending on the treatment.

Original languageEnglish
Pages (from-to)503-518
Number of pages16
JournalHealth Economics
Volume18
Issue number5
DOIs
Publication statusPublished - 2009 Jun 19
Externally publishedYes

Fingerprint

Infant Formula
Milk
Parents
Health
Cronobacter sakazakii
Therapeutics
Incidence

Keywords

  • Ambiguity
  • Experimental auction
  • Health risk information
  • Powdered infant milk formula
  • Willingness-to-pay

ASJC Scopus subject areas

  • Health Policy

Cite this

Parental response to health risk information : Experimental results on willingness-to-pay for safer infant milk formula. / Goldberg, Isabell; Roosen, Jutta; Nayga, Jr, Rodolfo M.

In: Health Economics, Vol. 18, No. 5, 19.06.2009, p. 503-518.

Research output: Contribution to journalArticle

Goldberg, Isabell ; Roosen, Jutta ; Nayga, Jr, Rodolfo M. / Parental response to health risk information : Experimental results on willingness-to-pay for safer infant milk formula. In: Health Economics. 2009 ; Vol. 18, No. 5. pp. 503-518.
@article{026f0417ab744ba8b3107e49e7bed7bf,
title = "Parental response to health risk information: Experimental results on willingness-to-pay for safer infant milk formula",
abstract = "Enterobacter sakazakii, a pathogen that can be found in powdered infant milk formula, can cause adverse health effects on infants. Using Vickrey auction, this study examines parents' willingness to pay (WTP) for a quality assurance label on powdered infant milk formula. The influence of ambiguity with the incidence rate information and provision of safe-handling information on WTP are also evaluated using three experimental treatments. Our findings generally imply that parents significantly value a quality assurance label. The mean price premium parents are willing to pay for the safer and quality assurance labelled powdered infant milk formula ranges from 61 to 133 Eurocents per 100 grams (53-116{\%} of the base price per 100 grams) depending on the treatment. While no ambiguity effects are generally found, provision of safe-handling information significantly reduced WTP to 39-69 Eurocents per 100 grams depending on the treatment.",
keywords = "Ambiguity, Experimental auction, Health risk information, Powdered infant milk formula, Willingness-to-pay",
author = "Isabell Goldberg and Jutta Roosen and {Nayga, Jr}, {Rodolfo M.}",
year = "2009",
month = "6",
day = "19",
doi = "10.1002/hec.1381",
language = "English",
volume = "18",
pages = "503--518",
journal = "Health Economics (United Kingdom)",
issn = "1057-9230",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Parental response to health risk information

T2 - Experimental results on willingness-to-pay for safer infant milk formula

AU - Goldberg, Isabell

AU - Roosen, Jutta

AU - Nayga, Jr, Rodolfo M.

PY - 2009/6/19

Y1 - 2009/6/19

N2 - Enterobacter sakazakii, a pathogen that can be found in powdered infant milk formula, can cause adverse health effects on infants. Using Vickrey auction, this study examines parents' willingness to pay (WTP) for a quality assurance label on powdered infant milk formula. The influence of ambiguity with the incidence rate information and provision of safe-handling information on WTP are also evaluated using three experimental treatments. Our findings generally imply that parents significantly value a quality assurance label. The mean price premium parents are willing to pay for the safer and quality assurance labelled powdered infant milk formula ranges from 61 to 133 Eurocents per 100 grams (53-116% of the base price per 100 grams) depending on the treatment. While no ambiguity effects are generally found, provision of safe-handling information significantly reduced WTP to 39-69 Eurocents per 100 grams depending on the treatment.

AB - Enterobacter sakazakii, a pathogen that can be found in powdered infant milk formula, can cause adverse health effects on infants. Using Vickrey auction, this study examines parents' willingness to pay (WTP) for a quality assurance label on powdered infant milk formula. The influence of ambiguity with the incidence rate information and provision of safe-handling information on WTP are also evaluated using three experimental treatments. Our findings generally imply that parents significantly value a quality assurance label. The mean price premium parents are willing to pay for the safer and quality assurance labelled powdered infant milk formula ranges from 61 to 133 Eurocents per 100 grams (53-116% of the base price per 100 grams) depending on the treatment. While no ambiguity effects are generally found, provision of safe-handling information significantly reduced WTP to 39-69 Eurocents per 100 grams depending on the treatment.

KW - Ambiguity

KW - Experimental auction

KW - Health risk information

KW - Powdered infant milk formula

KW - Willingness-to-pay

UR - http://www.scopus.com/inward/record.url?scp=67149100927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67149100927&partnerID=8YFLogxK

U2 - 10.1002/hec.1381

DO - 10.1002/hec.1381

M3 - Article

C2 - 18613316

AN - SCOPUS:67149100927

VL - 18

SP - 503

EP - 518

JO - Health Economics (United Kingdom)

JF - Health Economics (United Kingdom)

SN - 1057-9230

IS - 5

ER -